Amgen Inc. buy The Goldman Sachs Group, Inc.
Start price
07.02.24
/
50%
€289.60
Target price
07.02.25
€324.87
Performance (%)
-1.74%
End price
08.02.25
€284.55
Summary
This prediction ended on 08.02.25 with a price of €284.55. With a performance of -1.74%, the BUY prediction by The_Goldman_Sachs_Gr finished with a loss. The_Goldman_Sachs_Gr has a follow-up prediction for Amgen Inc. where he still thinks Amgen Inc. is a Buy. Dividends of €8.32 are taken into consideration when calculating the performance. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amgen Inc. | 3.004% | 3.004% | 9.523% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $313.00 to $350.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten